E. Sousa

发表

Intravascular-ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy: impact on long-term clinical follow-up

M. Leon, R. Mehran, G. Mintz, 2001, International journal of cardiovascular interventions.

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

Antonio Colombo, Patrick W Serruys, Michael Haude, 1998, The Lancet.

Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study.

P. Lemos, A. Abizaid, J. Mangione, 2011, JACC. Cardiovascular interventions.

Debate II: A randomized study to evaluate provisional stenting after guided balloon angioplasty.

P. Serruys, C. Vrints, J. Piek, 1998 .

862-2 Sirolimus-eluting stent implantation in routine clinical practice: A 12-month follow-up report from the international eCYPHER registry

P. Guyon, G. Guagliumi, A. Gershlick, 2004 .

Multivessel Coronary Disease Patients : Insights From the Arterial Revascularization Therapy Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of

G. Schuler, P. Hugenholtz, A. Abizaid, 2001 .

A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization

Patrick W. Serruys, P. Serruys, M. Morice, 2002 .

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

P. Serruys, B. Meier, M. Morice, 2006, JAMA.

Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.

Patrick W Serruys, Eduardo Sousa, Laura Mauri, 2007, Journal of the American College of Cardiology.

The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).

Frank Litvack, Patrick W Serruys, Eduardo Sousa, 2005, Journal of the American College of Cardiology.

Biodegradable-polymer-based, paclitaxel-eluting Infinnium stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study.

P. Serruys, E. Ribeiro, P. Lemos, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sirolimus-eluting coronary stents in small vessels.

S. Windecker, B. Meier, G. Guagliumi, 2006, American heart journal.

Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound.

P. Serruys, Chi‐Hang Lee, P. Lemos, 2003, The American journal of cardiology.

Drug‐Eluting Stents: Cost Versus Clinical Benefit

Pedro A. Lemos, Patrick W. Serruys, P. Serruys, 2003, Circulation.

EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions.

P. Fitzgerald, J. E. Sousa, R. Costa, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.